Atlas Trials

Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy

Clinical trial NCT05199103 · UNKNOWN

Trial details

NCT number
NCT05199103
Sponsor
Medical University of Silesia
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Graves Orbitopathy
Start date
2020-01-01
Primary completion
2023-12-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.